NCT02164045 Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529 Status COMPLETED Phase PHASE1
NCT02158507 Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer Status COMPLETED Phase NA
NCT02157467 Study of Combined Oral Contraceptive Effects in Female Subjects Status COMPLETED Phase PHASE1
NCT02153346 Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec Status COMPLETED Phase NA
NCT02153333 Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™ Status COMPLETED Phase N/A
NCT02153320 Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02152605 A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT02148211 Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry Status COMPLETED Phase N/A
NCT02145468 A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) Status COMPLETED Phase PHASE3
NCT02141230 Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union. Status WITHDRAWN Phase NA
NCT02141204 Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants Status COMPLETED Phase PHASE3
NCT02140762 Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Status COMPLETED Phase PHASE2
NCT02136875 Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation Status COMPLETED Phase PHASE4
NCT02135861 A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure Status COMPLETED Phase PHASE1
NCT02135718 ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma Status COMPLETED Phase N/A
NCT02135692 A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects Status COMPLETED Phase PHASE3
NCT02135666 Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) Status WITHDRAWN Phase PHASE4